The  	The  	 DT	O
involvement  	involvement  	 NN	O
of  	of  	 IN	O
RCAS1  	RCAS1  	 CD	B-NP
in  	in  	 IN	O
creating  	creating  	 VBG	O
a  	a  	 DT	O
suppressive  	suppressive  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
microenvironment  	microenvironment  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
pharyngeal  	pharyngeal  	 FW	B-NP
squamous  	squamous  	 FW	I-NP
cell  	cell  	 FW	I-NP
carcinoma  	carcinoma  	 FW	I-NP
Tumor  	Tumor  	 FW	I-NP
microenvironment  	microenvironment  	 FW	I-NP
makes  	makes  	 VBZ	O
up  	up  	 RP	O
the  	the  	 DT	O
stroma  	stroma  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
neoplasm  	neoplasm  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
that  	that  	 WDT	O
determines  	determines  	 VBZ	O
the  	the  	 DT	O
growth  	growth  	 NN	B-NP
and  	and  	 CC	O
progression  	progression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
create  	create  	 VB	O
metastases 	metastases 	 NNS	B-NP
.  	.  	 .	O
THE  	THE  	 DT	O
AIM  	AIM  	 NNP	O
OF  	OF  	 IN	O
THE  	THE  	 DT	O
PRESENT  	PRESENT  	 NNP	O
STUDY 	STUDY 	 NNP	O
:  	:  	 :	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
role  	role  	 NN	I-NP
of  	of  	 IN	I-NP
RCAS1  	RCAS1  	 CD	I-NP
protein  	protein  	 NN	I-NP
in  	in  	 IN	O
creating  	creating  	 VBG	O
the  	the  	 DT	O
suppressive  	suppressive  	 FW	B-NP
tumor  	tumor  	 FW	I-NP
microenvironment  	microenvironment  	 FW	I-NP
in  	in  	 FW	O
pharyngeal  	pharyngeal  	 FW	B-NP
squamous  	squamous  	 FW	I-NP
cell  	cell  	 FW	I-NP
carcinomas 	carcinomas 	 FW	I-NP
.  	.  	 .	O
The  	The  	 DT	O
immunoreactivity  	immunoreactivity  	 NN	B-NP
of  	of  	 IN	I-NP
RCAS1 	RCAS1 	 NNP	I-NP
,  	,  	 ,	O
CD3 	CD3 	 NNP	B-NP
,  	,  	 ,	O
CD25 	CD25 	 NNP	B-NP
,  	,  	 ,	O
CD68 	CD68 	 NNP	B-NP
,  	,  	 ,	O
CD69  	CD69  	 NNP	B-NP
and  	and  	 CC	O
Foxp3  	Foxp3  	 NNP	B-NP
was  	was  	 VBD	O
assessed  	assessed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
samples  	samples  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
tumor 	tumor 	 NN	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
tumor  	tumor  	 NN	B-NP
microenvironment  	microenvironment  	 NNS	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
reference  	reference  	 NN	B-NP
samples  	samples  	 NNS	I-NP
of  	of  	 IN	I-NP
palatine  	palatine  	 JJ	I-NP
tonsils  	tonsils  	 NN	I-NP
in  	in  	 IN	O
chronic  	chronic  	 JJ	B-NP
inflammation 	inflammation 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
statistically  	statistically  	 NN	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
RCAS1  	RCAS1  	 NN	B-NP
antigen  	antigen  	 NN	I-NP
immunoreactivity  	immunoreactivity  	 NNS	I-NP
was  	was  	 VBD	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
pharyngeal  	pharyngeal  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
samples  	samples  	 NNS	I-NP
than  	than  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
stromal  	stromal  	 JJ	B-NP
samples 	samples 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
RCAS1  	RCAS1  	 CD	B-NP
positive  	positive  	 JJ	I-NP
macrophages  	macrophages  	 NNS	I-NP
infiltrating  	infiltrating  	 VBG	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
stroma  	stroma  	 NN	B-NP
was  	was  	 VBD	O
also  	also  	 RB	O
noticed 	noticed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
statistically  	statistically  	 NN	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
RCAS1  	RCAS1  	 NN	B-NP
antigen  	antigen  	 NN	I-NP
immunoreactivity  	immunoreactivity  	 NN	I-NP
level  	level  	 NN	I-NP
was  	was  	 VBD	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
pharyngeal  	pharyngeal  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
samples  	samples  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
lymph  	lymph  	 JJ	B-NP
node  	node  	 JJ	I-NP
metastases  	metastases  	 NN	I-NP
in  	in  	 IN	O
comparison  	comparison  	 NN	O
to  	to  	 TO	O
patients  	patients  	 NNS	O
without  	without  	 IN	O
metastases 	metastases 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
infiltration  	infiltration  	 NN	B-NP
of  	of  	 IN	I-NP
CD68  	CD68  	 CD	I-NP
positive  	positive  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
macrophages 	macrophages 	 LS	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
the  	the  	 DT	O
stromal  	stromal  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
samples  	samples  	 NNS	I-NP
than  	than  	 IN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
samples  	samples  	 NNS	I-NP
and  	and  	 CC	O
it  	it  	 PRP	O
was  	was  	 VBD	O
in  	in  	 IN	O
both 	both 	 DT	O
,  	,  	 ,	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
stroma 	stroma 	 NN	B-NP
,  	,  	 ,	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
lymph  	lymph  	 JJ	B-NP
node  	node  	 JJ	I-NP
metastases  	metastases  	 NN	I-NP
than  	than  	 IN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
without  	without  	 IN	O
metastases 	metastases 	 NN	B-NP
.  	.  	 .	O
Additionally  	Additionally  	 RB	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
CD3  	CD3  	 CD	B-NP
positive  	positive  	 JJ	I-NP
TILs  	TILs  	 NN	I-NP
was  	was  	 VBD	O
noticed  	noticed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
its  	its  	 PRP$	O
stroma 	stroma 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
activated 	activated 	 VBN	O
,  	,  	 ,	O
typified  	typified  	 VBD	O
by  	by  	 IN	O
CD69  	CD69  	 CD	B-NP
immunoreactivity  	immunoreactivity  	 NNS	I-NP
which  	which  	 WDT	O
was  	was  	 VBD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
reference  	reference  	 NN	B-NP
samples 	samples 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
impaired  	impaired  	 JJ	O
cytotoxicity  	cytotoxicity  	 NN	B-NP
with  	with  	 IN	O
low  	low  	 JJ	O
CD25  	CD25  	 FW	B-NP
antigen  	antigen  	 FW	I-NP
immunoreactivity 	immunoreactivity 	 FW	I-NP
.  	.  	 .	O
This  	This  	 DT	O
observation  	observation  	 NN	O
confirmed  	confirmed  	 VBD	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
selective  	selective  	 JJ	B-NP
immune  	immune  	 JJ	I-NP
suppression  	suppression  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
stroma 	stroma 	 NN	B-NP
.  	.  	 .	O
RCAS1 	RCAS1 	 NNP	B-NP
,  	,  	 ,	O
an  	an  	 DT	O
active  	active  	 JJ	O
factor  	factor  	 NN	B-NP
secreted  	secreted  	 NN	I-NP
by  	by  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
and  	and  	 CC	O
present  	present  	 JJ	O
in  	in  	 IN	O
its  	its  	 PRP$	O
stroma  	stroma  	 NN	B-NP
may  	may  	 MD	O
play  	play  	 VB	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
phenomenon  	phenomenon  	 NN	O
of  	of  	 IN	O
tumor  	tumor  	 NN	B-NP
escape  	escape  	 NN	I-NP
from  	from  	 IN	O
host  	host  	 NN	B-NP
immunological  	immunological  	 NN	I-NP
surveillance  	surveillance  	 NN	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
creating  	creating  	 VBG	O
the  	the  	 DT	O
immune  	immune  	 JJ	O
tolerance  	tolerance  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
microenvironment  	microenvironment  	 NN	I-NP
remodeling  	remodeling  	 NN	I-NP
with  	with  	 IN	O
creating  	creating  	 VBG	O
its  	its  	 PRP$	O
suppressive  	suppressive  	 JJ	B-NP
profile  	profile  	 NN	I-NP
enabling  	enabling  	 VBG	O
the  	the  	 DT	O
further  	further  	 JJ	O
tumor  	tumor  	 NN	B-NP
growth  	growth  	 NN	I-NP
and  	and  	 CC	O
metastases 	metastases 	 NN	B-NP
.  	.  	 .	O
